Citigroup’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-300
Closed -$31K 5906
2022
Q2
$31K Hold
300
﹤0.01% 4771
2022
Q1
$39K Hold
300
﹤0.01% 4835
2021
Q4
$43K Sell
300
-100
-25% -$12.1K ﹤0.01% 5136
2021
Q3
$43K Hold
400
﹤0.01% 4812
2021
Q2
$42K Buy
+400
New +$38.4K ﹤0.01% 4904
2016
Q2
Sell
-180
Closed -$5K 7121
2016
Q1
$5K Buy
+180
New +$4.74K ﹤0.01% 6988

Other funds holding CURE

Citigroup's CURE Position: Q3 2022 in Review

Citigroup sold out of Direxion Daily Healthcare Bull 3X ETF (CURE) in Q3 2022, closing a stake of 300 shares — an estimated $31K sold.

Citigroup first reported a position in CURE in Q1 2016 and held it in 6 quarters. The position peaked at $43K in Q4 2021. 18 funds tracked by Wall St. Rank hold CURE as of Q3 2022.

  • Citigroup reported no remaining Direxion Daily Healthcare Bull 3X ETF position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 300 Direxion Daily Healthcare Bull 3X ETF shares in Q3 2022, an estimated $31K.
  • Citigroup first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q1 2016 and held it in 6 quarters.
  • Citigroup's Direxion Daily Healthcare Bull 3X ETF position peaked at $43K in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.